![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, October 22, 2015 6:54:46 PM
Where Titan still has the BIG advantage (in the aspect of time and commerce) is being further down along the regulatory pathway, thanks to Ximedica. They NEED! to capitalize on this and MUST ADVANCE! their near term potential to the marketplace in order to capitalize on what they have. If they move too slowly (because Reiza, Fowler, and Hargrove are out to save the world and all very nice guys) they will be overtaken. I do believe they may TRULY have a superior product at hand for this time and place, but that is all. If they have some MA in place, shout it out. And if not, still draw some attention to the potential of your product, you sh*t kickers from Canada.
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM